NCT03435796 2026-03-04Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T CellsCelgenePhase 2/3 Recruiting1,541 enrolled
NCT03927885 2026-02-19Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced CancerM.D. Anderson Cancer CenterPhase 2/3 Active not recruiting100 enrolled